Comparison of Zinc Oxide Eugenol to Ferric Sulphate Pulpotomy in Primary Teeth
A Clinical Trial Comparing Reinforced Zinc Oxide Eugenol to Ferric Sulphate as a Pulpotomy Agent in Primary Teeth
1 other identifier
interventional
65
1 country
1
Brief Summary
In this prospective randomized, single blinded; split-mouth clinical trial the aim was to evaluate clinical and radiographic effects of placement of reinforced zinc oxide eugenol (ZOE) base directly over the amputated pulp stumps in pulpotomized primary molars, and to compare this technique to ferric sulphate (FS) in pulpotomized primary teeth. Included were 65 children using a split-mouth design, (130 teeth). All teeth were then restored with prefabricated stainless steel crowns (SSC). Patients were recalled for clinical and radiographical evaluation after 3, 6, 12 and 24 months. Two experienced and calibrated pediatric dentists who were not involved in the investigation blindly assessed the radiographs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 2, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 2, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2014
CompletedFirst Submitted
Initial submission to the registry
February 24, 2023
CompletedFirst Posted
Study publicly available on registry
March 31, 2023
CompletedMarch 31, 2023
March 1, 2023
1 year
February 24, 2023
March 30, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of teeth which are asymptomatic without clinical signs of disease
including percussion sensitivity, spontaneous pain, mobility, or abscess (Clinical)
24 months
Number of teeth with no pathological changes present
including radiolucency, root or bone resorption (Radiographic)
24 months
Study Arms (2)
ZOE group
ACTIVE COMPARATORPulp hemostasis achieved by a dry cotton pellet applied on the pulp, then the chamber was filled with reinforced zinc oxide eugenol (ZOE) directly over the pulp.
FS group
ACTIVE COMPARATORPulp hemostasis achieved by a wet cotton pellet impregnated with ferric sulphate (FS) applied on the pulp, then the chamber was filled with (ZOE) directly over the pulp.
Interventions
Application of a dry cotton pellet, then the chamber was filled with ZOE directly over the pulp
Application of a a wet cotton pellet impregnated with FS, then the chamber was filled with ZOE directly over the pulp
Eligibility Criteria
You may qualify if:
- Healthy children
- Child has cooperative behaviour in the dental chair
- No history of spontaneous pain
- Deep caries in the tooth
- Carious exposure of a vital pulp
- A restorable tooth after completion of the pulp treatment
- Healthy periapical tissue on pre-operative periapical radiograph
You may not qualify if:
- Presence of tenderness to percussion and/or mobility
- Pathologic radiographic signs on pre-operative periapical radiograph including external or internal root resorption, calcification in the canal, periodontal membrane widening, periapical pathology, and furcation radiolucency.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jordan University of Science and Technology
Irbid, 22110, Jordan
Related Publications (15)
Briso AL, Rahal V, Mestrener SR, Dezan Junior E. Biological response of pulps submitted to different capping materials. Braz Oral Res. 2006 Jul-Sep;20(3):219-25. doi: 10.1590/s1806-83242006000300007.
PMID: 17119704BACKGROUNDCasas MJ, Layug MA, Kenny DJ, Johnston DH, Judd PL. Two-year outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatr Dent. 2003 Mar-Apr;25(2):97-102.
PMID: 12723832BACKGROUNDCasas MJ, Kenny DJ, Johnston DH, Judd PL. Long-term outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatr Dent. 2004 Jan-Feb;26(1):44-8.
PMID: 15080357BACKGROUNDChien MM, Setzer S, Cleaton-Jones P. How does zinc oxide-eugenol compare to ferric sulphate as a pulpotomy material? SADJ. 2001 Mar;56(3):130-5.
PMID: 16894712BACKGROUNDFei AL, Udin RD, Johnson R. A clinical study of ferric sulfate as a pulpotomy agent in primary teeth. Pediatr Dent. 1991 Nov-Dec;13(6):327-32.
PMID: 1843987BACKGROUNDHansen HP, Ravn JJ, Ulrich D. Vital pulpotomy in primary molars. A clinical and histologic investigation of the effect of zinc oxide-eugenol cement and Ledermix. Scand J Dent Res. 1971;79(1):13-25. No abstract available.
PMID: 5292960BACKGROUNDHui-Derksen EK, Chen CF, Majewski R, Tootla RG, Boynton JR. Retrospective record review: reinforced zinc oxide-eugenol pulpotomy: a retrospective study. Pediatr Dent. 2013 Jan-Feb;35(1):43-6.
PMID: 23635897BACKGROUNDHuth KC, Paschos E, Hajek-Al-Khatar N, Hollweck R, Crispin A, Hickel R, Folwaczny M. Effectiveness of 4 pulpotomy techniques--randomized controlled trial. J Dent Res. 2005 Dec;84(12):1144-8. doi: 10.1177/154405910508401210.
PMID: 16304444BACKGROUNDHuth KC, Hajek-Al-Khatar N, Wolf P, Ilie N, Hickel R, Paschos E. Long-term effectiveness of four pulpotomy techniques: 3-year randomised controlled trial. Clin Oral Investig. 2012 Aug;16(4):1243-50. doi: 10.1007/s00784-011-0602-3. Epub 2011 Aug 13.
PMID: 21842145BACKGROUNDIbricevic H, al-Jame Q. Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow-up. J Clin Pediatr Dent. 2000 Summer;24(4):269-72. doi: 10.17796/jcpd.24.4.d7u6405nw1132705.
PMID: 11314410BACKGROUNDMarkovic D, Zivojinovic V, Vucetic M. Evaluation of three pulpotomy medicaments in primary teeth. Eur J Paediatr Dent. 2005 Sep;6(3):133-8.
PMID: 16216093BACKGROUNDOliveira TM, Moretti AB, Sakai VT, Lourenco Neto N, Santos CF, Machado MA, Abdo RC. Clinical, radiographic and histologic analysis of the effects of pulp capping materials used in pulpotomies of human primary teeth. Eur Arch Paediatr Dent. 2013 Apr;14(2):65-71. doi: 10.1007/s40368-013-0015-x. Epub 2013 Apr 3.
PMID: 23549993BACKGROUNDPapagiannoulis L. Clinical studies on ferric sulphate as a pulpotomy medicament in primary teeth. Eur J Paediatr Dent. 2002 Sep;3(3):126-32.
PMID: 12871001BACKGROUNDWaterhouse PJ, Nunn JH, Whitworth JM, Soames JV. Primary molar pulp therapy--histological evaluation of failure. Int J Paediatr Dent. 2000 Dec;10(4):313-21. doi: 10.1046/j.1365-263x.2000.00211.x.
PMID: 11310245BACKGROUNDZurn D, Seale NS. Light-cured calcium hydroxide vs formocresol in human primary molar pulpotomies: a randomized controlled trial. Pediatr Dent. 2008 Jan-Feb;30(1):34-41.
PMID: 18402097BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Ola B. Al-Batayneh
Jordan University of Science and Technology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 24, 2023
First Posted
March 31, 2023
Study Start
January 2, 2013
Primary Completion
January 2, 2014
Study Completion
April 1, 2014
Last Updated
March 31, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share